REFERENCES
- Anomymous. Khat. E Drug Digest. 2007; 1–10, http://www.drugdisgest.org
- Alles GA. DL-beta-phenylisopropylamines. J Am Chem Soc. 1932; 54: 271–274
- WHO (World Health Organization) Expert Committee on Drug Dependence. Thirty-third report of the WHO Expert Committee on Drug Dependence. World Health Organization Technical Report Series No 915. 2006; Central Nervous System Stimulants, 1–21 and Cathinone, 23–24
- Lacherez S, D'Auzac P. Annual report about Yemen. Medecins Sans Frontieres 1998
- Alem A, Kebede D, Kullgren G. The prevalence and socio-demographic correlates of khat chewing in Butajira, Ethiopia. Acta Psychiatr Scand. 1999; 100: 84–91
- Pantelis C, Hindler CG, Taylor JC. Use and abuse of khat: A review of distribution, pharmacology, side effects and a description of psychosis attributed to khat chewing. Psychol Med. 2000; 19: 657–668
- Al-Sabry M. Knowledge, attitude, and practices towards Khat abuse. Unpublished paper from the University of Sana'a, Faculty of Medicine, Sana'a, Yemen
- Baasher TA, Sadoun R. The epidemiology of khat. International Conference on Khat—The Health and Socioeconomic Aspects of Khat Use. International Council on Alcohol and Addictions, Madagascar. 1983; 161–177
- Glennon RA, Yousif M, Naiman N, Kalix P. Methcathinone: A new and potent amphetamine-like agent. Pharmacol Biochem Behav. 1987; 26: 547–551
- http://www.phc.vcu.edu, Glennon RA. The cathinone page.